HUNTINGTON, NY, May 07, 2013 /24-7PressRelease/
-- Precision Eye Care announced today that it has installed a TearLab Osmolarity System and its staff has been fully trained on the use of this breakthrough technology. The center is one of the first in the Suffolk County, Long Island area to be able to offer TearLab
testing for Dry Eye Disease ("DED").
DED is a common condition in which the eye does not produce enough tears to keep the surface of the eye sufficiently lubricated. It affects approximately 40 million people in the U.S. and 100 million people worldwide. In the U.S., less than 5% of the Dry Eye Disease patient population has been diagnosed and is being treated, according to Healthcare Maintenance Organizations data. In its mild to moderate forms, it can impact vision and the ability to go about daily activities. In its more severe forms, DED can lead to permanent loss of vision.
The TearLab Osmolarity System uses a novel lab-on-a-chip approach to measure tear osmolarity and can produce a sample-to-answer result in less than 30 seconds. TearLab eliminates the challenges that previously prevented accurate point-of-care testing for osmolarity.
Dr. Richard G. Davis, a specialist in laser cataract surgery
and an area leader in the field of Dry Eye management, said, "Today's announcement further demonstrates our commitment to building a practice that is dedicated to providing the highest quality of care using advanced ophthalmic diagnostic techniques and treatments. Equipped with the TearLab Osomolarity System, we can now use quantitative data at the point of care to aid in the diagnosis of DED and to improve our ability to manage these patients."
People looking for information on this new technology can contact Precision Eye Care at 631-462-2020 or visit their website
About Precision Eye Care
Precision Eye Care is one of the most advanced Eye Care Centers on Long Island. Dr. Richard Davis
, founder of Precision Eye Care and leader in the ophthalmic community, has continued to provide cutting edge technology for his patients on Long Island for over 20 years. Precision Eye Care offers the newest technology in Femtosecond Laser Cataract Surgery and they continually seek new and proven diagnostic technologies to offer patients. Dr. Davis has performed over 20,000 eye surgeries and is considered one of the elite eye surgeons in the Long Island, New York area.
About TearLab Corporation
TearLab Corporation (www.tearlab.com
) develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The TearLab Osmolarity Test, for diagnosing Dry Eye Disease, is the first assay developed for the award-winning TearLab Osmolarity System. Headquartered in San Diego, CA, TearLab Corporation's common shares trade on the NASDAQ Capital Market under the symbol 'TEAR' and on the Toronto Stock Exchange under the symbol 'TLB'.